EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Heparin resistance management during cardiac surgery: a literature review and future directions

Salman Pervaiz Butt, Vivek Kakar, Arun Kumar, Nabeel Razzaq, Yasir Saleem, Babar Ali, Nuno Raposo, Fazil Ashiq, Arshad Ghori, Philip Anderson, Nilesh Srivatav, Yazan Aljabery und 3 weitere

The Journal of ExtraCorporeal Technology · 2024

DOI: 10.1051/ject/2024015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of ExtraCorporeal Technology, 2024. Verfasst von Salman Pervaiz Butt und 14 weiteren Autor:innen. Beteiligte Einrichtung: Perfusion Services, Heart Vascular and Thoracic Institute, Cleveland Clinic, PO BOX 112412, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Heparin, Cardiac Surgical Procedures, Anticoagulants, Drug Resistance. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heparin, a commonly used anticoagulant in cardiac surgery, binds to antithrombin III (ATIII) to prevent clot formation. However, heparin resistance (HR) can complicate surgical procedures, leading to increased thromboembolic risks and bleeding complications. Proper diagnosis and management of HR are essential for optimizing surgical outcomes. Methodology : Diagnosis of HR involves assessing activated clotting time (ACT) and HR assays. Management strategies were identified through a comprehensive review of the literature, including studies exploring heparin dosage adjustments, antithrombin supplementation, and alternative anticoagulants in cardiac surgery patients with HR. A thorough search of relevant studies on HR was conducted using multiple scholarly databases and relevant keywords, resulting in 59 studies that met the inclusion criteria.

Discussion

HR occurs when patients do not respond adequately to heparin therapy, requiring higher doses or alternative anticoagulants. Mechanisms of HR include AT III deficiency, PF4 interference, and accelerated heparin clearance. Diagnosis involves assessing ACT and HR assays. HR in cardiac surgery can lead to thromboembolic events, increased bleeding, prolonged hospital stays, and elevated healthcare costs. Management strategies include adjusting heparin dosage, supplementing antithrombin levels, and considering alternative anticoagulants. Multidisciplinary management of HR involves collaboration among various specialities. Strategies include additional heparin doses, fresh frozen plasma (FFP) administration, and antithrombin concentrate supplementation. Emerging alternatives to heparin, such as direct thrombin inhibitors and nafamostat mesilate, are also being explored.

Conclusion

Optimizing the management of HR is crucial for improving surgical outcomes and reducing complications in cardiac surgery patients. Multidisciplinary approaches and emerging anticoagulation strategies hold promise for addressing this challenge effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinCardiac Surgical ProceduresAnticoagulantsDrug ResistanceHumansThromboembolism

Stichwörter der Autor:innen

Activated clotting timeAnti-thrombinAnticoagulationCardiac surgeryHeparin resistance

Substanzen

HeparinAnticoagulants

Autor:innen und Institutionen

  • Perfusion Services, Heart Vascular and Thoracic Institute, Cleveland Clinic, PO BOX 112412, Abu Dhabi, United Arab Emirates.
  • Critical Care Institute, Cleveland Clinic, PO BOX 112412, Abu Dhabi, United Arab Emirates - Cleveland Clinic Lerner College of Medicine, Western Reserve University, 44195 Ohio, USA.
  • Anesthesiology Institute, Cleveland Clinic, PO BOX 112412, Abu Dhabi, United Arab Emirates.
  • Cardiothoracic Surgery Department Heart and Vascular Institute, Cleveland Clinic, PO BOX 112412, Abu Dhabi, United Arab Emirates.
  • All India Institute of Medical Sciences, 110029 New Delhi, India.
  • Department of Cardiac Perfusion Technology, Khyber Medical University, 25100 Peshawar, Pakistan.

Zitieren

APA

Butt, S. P., Kakar, V., Kumar, A., Razzaq, N., Saleem, Y., Ali, B., Raposo, N., Ashiq, F., Ghori, A., Anderson, P., Srivatav, N., Aljabery, Y., Abdulaziz, S., Darr, U., & Bhatnagar, G. (2024). Heparin resistance management during cardiac surgery: a literature review and future directions. The Journal of ExtraCorporeal Technology. https://doi.org/10.1051/ject/2024015

Vancouver

Butt SP, Kakar V, Kumar A, Razzaq N, Saleem Y, Ali B, et al. Heparin resistance management during cardiac surgery: a literature review and future directions. The Journal of ExtraCorporeal Technology. 2024. doi:10.1051/ject/2024015

BibTeX
@article{Butt2024,
  author = {Butt, Salman Pervaiz and Kakar, Vivek and Kumar, Arun and Razzaq, Nabeel and Saleem, Yasir and Ali, Babar and Raposo, Nuno and Ashiq, Fazil and Ghori, Arshad and Anderson, Philip and Srivatav, Nilesh and Aljabery, Yazan and Abdulaziz, Salman and Darr, Umer and Bhatnagar, Gopal},
  title = {Heparin resistance management during cardiac surgery: a literature review and future directions},
  journal = {The Journal of ExtraCorporeal Technology},
  year = {2024},
  doi = {10.1051/ject/2024015}
}
Kostenlos starten →